6
Participants
Start Date
February 19, 2015
Primary Completion Date
July 1, 2016
Study Completion Date
August 1, 2016
Rosuvastatin10 mg tablet
Commercially available Rosuvastatin 10 mg tablets will be supplied. Single oral dose of Rosuvastatin 10 mg will be administered on Day 1, 8 and 22
Midazolam 3 mg syrup
Commercially available Midazolam syrup will be supplied.Single oral dose of Midazolam 3 mg syrup will be administered on Days 1, 8 and 22
Dabrafenib 75 mg capsule
Dabrafenib 75mg will be supplied in the form of capsules. Oral dose Dabrafenib 150 mg (2 x 75 mg) BID will be administered at 12 h apart on Days 8 through 22 and 150 mg (2 x 75 mg) OD on Day 23.
GSK Investigational Site, Madrid
GSK Investigational Site, Seville
GSK Investigational Site, Lebanon
GSK Investigational Site, Barcelona
Lead Sponsor
GlaxoSmithKline
INDUSTRY